Pharmafile Logo
Pharmafocus logo
Advanced Search

Zetia-Zocor marketing to focus on efficacy

December 8, 2003
Sales and Marketing

Merck and Schering-Plough have indicated that efficacy and not safety will be the focus of their up-and-coming cholesterol combination drug.Merck …

News

Expert resigns over HRT warning

December 8, 2003

New guidance advising doctors not to use hormone replacement therapy to treat osteoporosis has prompted the resignation of a senior …

News

New foundation trust watchdog appointed

December 4, 2003

The head of the new independent watchdog to monitor NHS foundation trusts has been named as Bill Moyes, current Director-General …

News

Don’t get frozen out

December 4, 2003
Sales and Marketing marketing, sales, strategy

A fundamental change is underway in the European healthcare sector. The traditional autonomy of the physician has yielded to more …

Feature

Biotech grows up

December 4, 2003
Research and Development, Sales and Marketing alliances, biotech, partnerships, pharma

Sometimes it is hard to see where the fun lies in running a biotechnology company. Discounting the obvious success stories …

Feature

MEPs look for progress on patient information

November 28, 2003

MEPs have put forward new proposals to provide patients and the public with greater information on medicines, in an attempt …

News

Stronger warnings for COX-IIs recommended

November 28, 2003

A European Union safety review of the COX-II inhibitor class of drugs has recommended stronger labelling for painkiller treatments for …

News

GSK loses Augmentin patent battle to Novartis

November 28, 2003

News

Medicare reform will expand US market

November 27, 2003
Medicare, US, healthcare reform

 America’s long-awaited reform of the Medicare health insurance system has received the backing of both Houses of government, giving over …

News

Making the most of medicines

November 26, 2003
Sales and Marketing NHS, healthcare, medicines management

Feature

Call to action after breakthrough on patents

November 26, 2003

The World Health Organisation has called for massively increased efforts to distribute antiretrovirals in the developing world to cut unnecessary …

News

Red Door’s hepatitis campaign wins top PR prize

November 26, 2003

Red Door Communications has scooped several top prizes at the prestigious PR Week Awards including one for its  hepatitis B …

News

Trials agency to spearhead bioscience drive

November 26, 2003

News

Pipeline promises $10 billion says Novartis

November 25, 2003

Novartis has unveiled details of major new drugs in its pipeline which it says could produce annual sales of $10 …

News

FDA claims victory after medicines importer shutdown

November 25, 2003

The FDA has claimed a significant victory in its battle against imports of prescription medicines from Canada after a court …

News

FDA chief attacks Europe price controls

November 24, 2003

The chief US medicines regulator has attacked price controls in Europe, saying the practice denies its patients access to medicines …

News

Finances threaten Cambridge neuroscience centre

November 24, 2003

News

Government backs over the counter Zocor

November 21, 2003

The Government has declared its strong backing for statins to be made available to consumers over the counter as early …

News

Developing boardroom excellence

November 21, 2003
Business Services non-executive directors, recruitment

Feature

Government and pharma strike new NRT ‘kickback’ deal

November 21, 2003

GlaxoSmithKline, Pfizer and Novartis have all agreed special new deals with the government to provide extra smoking cessation products to …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026